$NWBO Recent Headlines 7 Biotechnology Stocks
Post# of 44960
Posted On: 09/06/2014 1:02:13 PM
$NWBO Recent Headlines
7 Biotechnology Stocks to Buy Now 5:30 a.m. Sept. 3, 2014 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 6:00 a.m. Aug. 27, 2014 - InvestorPlace.com
Northwest Bio closes convertible debt offering 4:41 p.m. Aug. 25, 2014 - Seeking Alpha
8 Biotechnology Stocks to Buy Now 6:15 a.m. Aug. 20, 2014 - InvestorPlace.com
8 Biotechnology Stocks to Buy Now 6:15 a.m. Aug. 20, 2014 - InvestorPlace.com
Northwest Bio Can't Keep its DC-Vax Claims Straight 10:20 a.m. Aug. 14, 2014 - TheStreet.com
10 Cheap Stocks to Buy Now Under $10 10:20 a.m. Aug. 14, 2014 - InvestorPlace.com
Northwest Bio: The Data Monitoring Committee Addresses The Status Of The DCVax-L Trial 6:17 p.m. Aug. 13, 2014 - Seeking Alpha
Northwest Bio - You Can See This Data, But Not That Data 9:35 a.m. Aug. 13, 2014 - Seeking Alpha
9 Biotechnology Stocks to Buy Now 6:15 a.m. Aug. 13, 2014 - InvestorPlace.com
Northwest Bio DC-Vax Study Changes Hint at Failure 11:18 a.m. Aug. 12, 2014 - TheStreet.com
Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies 10:43 a.m. Aug. 12, 2014 - Seeking Alpha
8 Biotechnology Stocks to Buy Now 5:00 a.m. Aug. 6, 2014 - InvestorPlace.com
11 Biotechnology Stocks to Buy Now 5:45 a.m. July 30, 2014 - InvestorPlace.com
7 Biotechnology Stocks to Buy Now 6:00 a.m. July 23, 2014 - InvestorPlace.com
Northwest Bio And The Curious Relationship With Cognate BioServices 6:55 p.m. July 17, 2014 - Seeking Alpha
Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Scheme To Promote NWBO 8:25 a.m. July 17, 2014 - Seeking Alpha
Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Promotion Scheme 8:25 a.m. July 17, 2014 - Seeking Alpha
7 Biotechnology Stocks to Buy Now 6:30 a.m. July 16, 2014 - InvestorPlace.com
Why Immunotherapies Have Made DelMar's Lead Drug A Necessity In Brain Cancer 2:40 p.m. July 15, 2014 - Seeking Alpha
NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 2:44 p.m. Aug. 19, 2014 - PR Newswire - PRF
NW BIO ANNOUNCES PRICING OF $17.5 MILLION OFFERING OF CONVERTIBLE NOTES 11:47 a.m. Aug. 14, 2014 - PR Newswire - PRF
NW BIO CORRECTS ONGOING FALSE CLAIMS BY FEUERSTEIN ABOUT PHASE III TRIAL OF DCVAX®-L, AND INTERIM ANALYSIS 9:26 a.m. Aug. 13, 2014 - PR Newswire - PRF
NW BIO OBTAINS APPROVALS FOR ENHANCEMENTS OF PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER 8:15 a.m. Aug. 11, 2014 - PR Newswire - PRF
NW BIO PROVIDES UPDATE ABOUT PHASE III DCVAX®-L TRIAL FOR GBM AND "INFORMATION ARM" COMPASSIONATE USE PATIENTS 8:15 a.m. Aug. 11, 2014 - PR Newswire - PRF
Small companies lead the I-O class of Cancer Therapies 8:02 a.m. Aug. 8, 2014 - ACCESSWIRE
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 4:45 p.m. July 30, 2014 - BusinessWire - BZX
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Northwest Biotherapeutics, Inc. Stockholders 7:13 p.m. July 23, 2014 - BusinessWire - BZX
NW BIO ANNOUNCES COMPLETION OF DCVAX®-DIRECT PHASE I TRIAL RECRUITMENT 8:15 a.m. July 16, 2014 - PR Newswire - PRF
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 4:55 p.m. July 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 6:23 p.m. July 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Northwest Biotherapeutics, Inc. - NWBO 6:31 p.m. July 7, 2014 - PR Newswire - PRF
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Northwest Biotherapeutics, Inc. (NWBO) To Contact The Firm 1:17 p.m. July 4, 2014 - PR Newswire - PRF
Biotech Stocks on the Move -- Research on CTI BioPharma, BioMarin Pharma, Vertex Pharma, and Northwest Biotherapeutics 7:00 a.m. June 27, 2014 - PR Newswire - PRF
Completed Acquisitions, Index Inclusions, and Conditional Drug Approvals - Analyst Notes on Universal Health Services, Brookdale, Envision Healthcare, Karyopharm and NW Bio 5:30 a.m. June 26, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 4:50 p.m. June 25, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Northwest Biotherapeutics, Inc. -- NWBO 5:37 p.m. June 23, 2014 - GlobeNewswire
NW BIO REAFFIRMS DCVAX®-DIRECT CLINICAL TRIAL INTERIM DATA ANNOUNCEMENTS 8:25 a.m. June 20, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Investigation on Behalf of Northwest Biotherapeutics, Inc. Investors Announced by Law Offices of Howard G. Smith 4:32 p.m. June 19, 2014 - BusinessWire - BZX
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Northwest Biotherapeutics, Inc. 2:30 p.m. June 19, 2014 - PR Newswire - PRF
7 Biotechnology Stocks to Buy Now 5:30 a.m. Sept. 3, 2014 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 6:00 a.m. Aug. 27, 2014 - InvestorPlace.com
Northwest Bio closes convertible debt offering 4:41 p.m. Aug. 25, 2014 - Seeking Alpha
8 Biotechnology Stocks to Buy Now 6:15 a.m. Aug. 20, 2014 - InvestorPlace.com
8 Biotechnology Stocks to Buy Now 6:15 a.m. Aug. 20, 2014 - InvestorPlace.com
Northwest Bio Can't Keep its DC-Vax Claims Straight 10:20 a.m. Aug. 14, 2014 - TheStreet.com
10 Cheap Stocks to Buy Now Under $10 10:20 a.m. Aug. 14, 2014 - InvestorPlace.com
Northwest Bio: The Data Monitoring Committee Addresses The Status Of The DCVax-L Trial 6:17 p.m. Aug. 13, 2014 - Seeking Alpha
Northwest Bio - You Can See This Data, But Not That Data 9:35 a.m. Aug. 13, 2014 - Seeking Alpha
9 Biotechnology Stocks to Buy Now 6:15 a.m. Aug. 13, 2014 - InvestorPlace.com
Northwest Bio DC-Vax Study Changes Hint at Failure 11:18 a.m. Aug. 12, 2014 - TheStreet.com
Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies 10:43 a.m. Aug. 12, 2014 - Seeking Alpha
8 Biotechnology Stocks to Buy Now 5:00 a.m. Aug. 6, 2014 - InvestorPlace.com
11 Biotechnology Stocks to Buy Now 5:45 a.m. July 30, 2014 - InvestorPlace.com
7 Biotechnology Stocks to Buy Now 6:00 a.m. July 23, 2014 - InvestorPlace.com
Northwest Bio And The Curious Relationship With Cognate BioServices 6:55 p.m. July 17, 2014 - Seeking Alpha
Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Scheme To Promote NWBO 8:25 a.m. July 17, 2014 - Seeking Alpha
Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Promotion Scheme 8:25 a.m. July 17, 2014 - Seeking Alpha
7 Biotechnology Stocks to Buy Now 6:30 a.m. July 16, 2014 - InvestorPlace.com
Why Immunotherapies Have Made DelMar's Lead Drug A Necessity In Brain Cancer 2:40 p.m. July 15, 2014 - Seeking Alpha
NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING 2:44 p.m. Aug. 19, 2014 - PR Newswire - PRF
NW BIO ANNOUNCES PRICING OF $17.5 MILLION OFFERING OF CONVERTIBLE NOTES 11:47 a.m. Aug. 14, 2014 - PR Newswire - PRF
NW BIO CORRECTS ONGOING FALSE CLAIMS BY FEUERSTEIN ABOUT PHASE III TRIAL OF DCVAX®-L, AND INTERIM ANALYSIS 9:26 a.m. Aug. 13, 2014 - PR Newswire - PRF
NW BIO OBTAINS APPROVALS FOR ENHANCEMENTS OF PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER 8:15 a.m. Aug. 11, 2014 - PR Newswire - PRF
NW BIO PROVIDES UPDATE ABOUT PHASE III DCVAX®-L TRIAL FOR GBM AND "INFORMATION ARM" COMPASSIONATE USE PATIENTS 8:15 a.m. Aug. 11, 2014 - PR Newswire - PRF
Small companies lead the I-O class of Cancer Therapies 8:02 a.m. Aug. 8, 2014 - ACCESSWIRE
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 4:45 p.m. July 30, 2014 - BusinessWire - BZX
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Northwest Biotherapeutics, Inc. Stockholders 7:13 p.m. July 23, 2014 - BusinessWire - BZX
NW BIO ANNOUNCES COMPLETION OF DCVAX®-DIRECT PHASE I TRIAL RECRUITMENT 8:15 a.m. July 16, 2014 - PR Newswire - PRF
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 4:55 p.m. July 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 6:23 p.m. July 9, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Northwest Biotherapeutics, Inc. - NWBO 6:31 p.m. July 7, 2014 - PR Newswire - PRF
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Northwest Biotherapeutics, Inc. (NWBO) To Contact The Firm 1:17 p.m. July 4, 2014 - PR Newswire - PRF
Biotech Stocks on the Move -- Research on CTI BioPharma, BioMarin Pharma, Vertex Pharma, and Northwest Biotherapeutics 7:00 a.m. June 27, 2014 - PR Newswire - PRF
Completed Acquisitions, Index Inclusions, and Conditional Drug Approvals - Analyst Notes on Universal Health Services, Brookdale, Envision Healthcare, Karyopharm and NW Bio 5:30 a.m. June 26, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc. 4:50 p.m. June 25, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Northwest Biotherapeutics, Inc. -- NWBO 5:37 p.m. June 23, 2014 - GlobeNewswire
NW BIO REAFFIRMS DCVAX®-DIRECT CLINICAL TRIAL INTERIM DATA ANNOUNCEMENTS 8:25 a.m. June 20, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Investigation on Behalf of Northwest Biotherapeutics, Inc. Investors Announced by Law Offices of Howard G. Smith 4:32 p.m. June 19, 2014 - BusinessWire - BZX
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Northwest Biotherapeutics, Inc. 2:30 p.m. June 19, 2014 - PR Newswire - PRF
(0)
(0)